TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2024

Adjuvant Trastuzumab Emtansine Versus Paclitaxel Plus Trastuzumab for Stage I Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: 5-Year Results and Correlative Analyses From ATEMPT.

Paolo Tarantino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.